- Framework may also help protect dementia patients
- One researcher attributes Watson's failure in cancer diagnosis to a lack of emotion in the data
BPU Holdings... read more
BPU Holdings... read more
... read more
Galecto Biotech AB, the leading developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, today announced the successful closing of a €79 million series... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,